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OBJECTIVE: An awareness of the repeatability of biological measures is required to properly design and calculate
sample sizes for longitudinal interventional studies. We investigated the day-to-day repeatability of measures of
systemic microvascular reactivity using laser Doppler perfusion monitoring.
METHODS: We performed laser Doppler perfusion monitoring in combination with skin iontophoresis using
acetylcholine and sodium nitroprusside as well as post-occlusive reactive and thermal hyperemia twice within two
weeks. The repeatability was assessed by calculating the within-subject standard deviations, limits of agreement,
typical errors and intra-class correlation coefficients between days 1 and 2. The ratio of the within-subject standard
deviation to the mean values obtained on days 1 and 2 (within-subject standard deviation/GM) was used to
determine the condition with the best repeatability.
RESULTS: Twenty-four healthy subjects, aged 24.6¡3.8 years, were recruited. The area under the curve of the
vasodilatory response to post-occlusive reactivity showed marked variability (within-subject standard deviation/GM
=0.83), while the area under the curve for acetylcholine exhibited less variability (within-subject standard deviation/
GM =0.52) and was comparable to the responses to sodium nitroprusside and thermal treatment (within-subject
standard deviations/GM of 0.67 and 0.56, respectively). The area under the blood flow/time curve for vasodilation
during acetylcholine administration required the smallest sample sizes, the area under the blood flow/time curve
during post-occlusive reactivity required the largest sample sizes, and the area under the blood flow/time curves of
vasodilation induced by sodium nitroprusside and thermal treatment required intermediate sizes.
CONCLUSIONS: In view of the importance of random error related to the day-to-day repeatability of laser Doppler
perfusion monitoring, we propose an original and robust statistical methodology for use in designing prospective
clinical studies.
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During the last two decades, it has become apparent that
endothelial dysfunction is a central phenomenon in the
pathophysiology of cardiovascular and metabolic diseases.
1,2
Endothelial dysfunction is also considered to be a specific
marker of atherosclerotic risk
3–5 and is now widely recog-
nized as the earliest clinically detectable indication of
subclinical atherosclerosis.
6 Moreover, due to the systemic
nature of endothelial dysfunction, which simultaneously
affects the coronary circulation and peripheral vascular
beds,
7 it has become clear that endothelial dysfunction in
conduit arteries, small-resistance vessels and the microcircu-
lation can be used as a surrogate marker for coronary
endothelial damage.
8,9 Assessing peripheral endothelial
function can also be useful for establishing a correlation
between improvements in endothelial function after ther-
apeutic interventions and improvements in cardiovascular
outcomes.
10–13
Due to the clinical relevance for the prediction of long-
term cardiovascular risk, therefore, there is growing interest
in assessing endothelial-dependent vasodilatation using
non-invasive techniques.
9,14 Skin laser Doppler perfusion
monitoring (LDPM) coupled with the delivery of vasoactive
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599drugs across the skin using iontophoresis is increasingly
being used for the clinical evaluation of microvascular
endothelial function.
15 Nevertheless, the use of single-point
LDPM has some pitfalls that can interfere with its useful-
ness in the clinical setting and possibly preclude compar-
isons of results obtained by different investigators. The main
concern is the poor reproducibility of the methodology,
which is mainly due to the spatial heterogeneity of skin
blood flow (for LDPM)
16,17 and differences in skin resistance
(for iontophoresis).
18 The use of standard, well-defined
experimental protocols and the proper expression of
cutaneous blood flow changes in response to different
stimuli may improve the reproducibility of LDPM.
19 One
major concern is the repeatability of the methodology, given
that the sequential assessment of endothelial function is
mandatory for evaluating medical interventions in cardio-
metabolic diseases. Finally, most studies in the literature
that investigate endothelial function using LDPM are cross-
sectional and do not consider the variability of the
methodology when calculating the statistical power and
the sample size.
The present study was designed to investigate the day-to-
day repeatability of skin LDPM measurements coupled with
physiological and pharmacological local vasodilatory sti-
muli in young, healthy volunteers. In view of our results, we
propose the use of a statistical methodology that takes the
repeatability of LDPM into consideration when calculating




This study was performed on 24 healthy volunteers
without any underlying diseases (hospital employees and
medical students). No subjects were taking any medications,
and they were all judged to be healthy on the basis of a
physical examination and routine laboratory screening,
which revealed normal lipid and glycemic profiles. Each
subject was studied twice in two weeks (all of the subjects
were tested at 7-day intervals). The testing occurred in the
morning after a 20-minute rest period; subjects were
instructed to assume the supine position in a metabolic
unit with a controlled temperature (23¡1uC) after an
overnight fast. The subjects were instructed to refrain from
drinking alcohol- or caffeine-containing beverages and from
exercising for at least 12 hours before the study. The study
was approved by the local ethics committee, and the
participants gave written informed consent.
Evaluation of microvascular reactivity to
pharmacological stimulation
Endothelium-dependent and -independent perfusion
changes resulting from vasodilatation of the skin micro-
circulation (measured in perfusion units, PU=10 mV) were
noninvasively and continuously evaluated using an LDPM
system in combination with iontophoresis (Periflux 5001
and PeriIont, Perimed, Ja ¨rfa ¨lla, Sweden) of acetylcholine
(ACh) and sodium nitroprusside (SNP). Drug-delivery
electrodes (PF 383, Perimed) were incorporated into the
head of the laser probe (PF 481-1, Perimed), and the probe
temperature was standardized to 32uC to avoid variations in
skin temperature and, consequently, in the measurements of
microvascular flow. The drug-delivery electrodes were
filled with 200 ml of 0.1 g/L ACh (Sigma Chemical CO,
USA) dissolved in distilled water and were attached with
the laser probe to a standardized site on the forearm (2–3 cm
from the wrist) that had no visible veins. The dispersive
electrode was attached approximately 15 cm away from the
electrophoresis chamber, according to the manufacturer’s
instructions. After measuring the resting flow for 5 minutes,
4 doses of ACh were delivered using an anodal current
(0.1 mA for 10, 20, 40 and 80 seconds, with total charges of 1,
2, 4 and 8 millicoulombs) at 120-second intervals. The mean
values of the resting flow were considered to be the basal
flow values for each patient. Using a new delivery electrode
applied to a different location on the same forearm, four
doses of a solution of 0.1 g/L SNP (Sigma Chemical CO,
USA) dissolved in distilled water were delivered using a
cathodal current (with the same charges and intervals as for
ACh). The curves of the microvascular flow increases
induced by ACh and SNP always had a total recording
time of 10 minutes: 2 minutes for each dose and 2 minutes to
reach the plateau response after the last dose. Previous data
from our group showed that the maximum responses to
both ACh and SNP occur during this time interval
(unpublished observations).
Physiological stimulation
After measuring the resting flow for 5 minutes using
another laser probe (PF 457, Perimed) that had been
positioned at the beginning of the recordings, the post-
occlusive reactive hyperemia (PORH) test was performed
by placing the cuff of a sphygmomanometer on the distal
portion of the subjects’ arms and achieving arterial occlu-
sion by increasing the pressure to 50 mmHg above the
systolic blood pressure over a 3-minutes interval (biological
zero). Following the release of the pressure, the maximum
flow, time to maximum flow (TM), time to half recovery
after hyperemia (TH2) and the area under the PORH curve
were measured using a heating probe (PF 457, Perimed).
Using PeriSoft for Windows 2.5 (Perimed, Ja ¨rfa ¨lla, Sweden),
the curve of the PORH was calculated from the release of
the cuff until the flow value had returned to the basal value.
The mean value of the resting flow was considered to be the
basal flow value.
When the microvascular flow had returned to the basal
value after the PORH (typically 5–10 minutes), we investi-
gated the maximal skin microvascular vasodilatation using
prolonged (20 minutes) local heating of the laser probe to
44uC. The baseline microvascular flow value was calculated
as described above. The use of the area under the blood
flow/time curve (AUC) for assessing skin microvascular
reactivity using LDPM is well validated because it repre-
sents the global flow response to different physiological and
pharmacological stimuli.
20–22 The AUC was calculated
using PeriSoft for Windows 2.5 (Perimed, Ja ¨rfa ¨lla, Sweden).
The four different stimulations described above (ACh,
SNP, PORH and heating) were performed consecutively.
Data and statistical analysis
The values obtained for the different parameters are
presented as the mean and standard deviation for each
study day. An analysis of the day-to-day repeatability was
carried out using the limits of agreement (LA), within-
subject standard deviation (WSSD), typical error (TE) and
intraclass correlation coefficient (ICC).
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,where n is the sample size and d is
the number of measurements obtained for each subject. The
WSSD was used in the calculations of the sample sizes.
Thetypicalerror wascalculatedasdescribedpreviouslyby
Hopkins




standard deviation of the differences between measurements
(the day-to-day repeatability) is divided by the square root of
the number of measurements (two in this case).
The ICC was calculated using the formula described by
McGraw and Wong (24), ICC~
MSR{MSE
MSRz k{1 ðÞ MSE
, where
MS is the square root of the mean between the subjects (R)
or the error (E) from a two-way ANOVA table, and k is the
number of values per group. The significance of the mean
error between days 1 and 2 was evaluated using the t-test
for dependent samples (the paired t-test), with an a of
0.0125 (a of 0.05 adjusted for multiple comparisons by the
Bonferroni method).
Considering that there was a correlation between the
error (the day-to-day variability) and the magnitude of the
measurements, the data were log-transformed to calculate
the limits of agreement, in keeping with the approach of
Bland and Altman.
25 In this case, the limits of agreement
were found to be a multiplicative function instead of an
additive one.
The sample sizes were calculated according to the
formula of Arango (26) for longitudinal studies. The size
of each group is given by n~2: za
2zz1{b
   2: WSSD
MDE
   2
,
where WSSD is the within-subject standard deviation, and
(as described above) MDE indicates the minimum differ-
ence expected between the groups. Using a=0.05 (za/2
=1.96) and b=0.20 (z1-b=0.84), we can simplify the formula
to n~8: WSSD
MDE
   2
. We also calculated the minimum
statistically significant differences for different levels of
microvascular reactivity according to the sample size of the
hypothetical study populations. To compare the measure-
ment techniques under consideration and to determine
which is the most stable and adequate, we calculated a
global mean (the mean of all of the individual values for the
same technique at days 1 and 2) and divided the WSSD by
this global mean. The technique with the smallest ratio
between the WSSD and the global mean was considered to
be the most suitable measurement for clinical studies.
RESULTS
Study sample
This cross-sectional study included 24 healthy subjects (11
males) aged 24.6¡3.8 years, with an average body mass
index of 23.0¡3.4 kg/m
2. The systolic and diastolic arterial
pressures on day 1 were 114.8¡2.1 and 69.4¡5.0 mmHg,
respectively. On day 2, the systolic and diastolic arterial
pressures were 114.3¡2.3 and 68¡0.9 mmHg, respectively.
There were no significant differences in the values of the
arterial pressure between days 1 and 2. All of the subjects
had normal lipid and glycemic profiles, and all of the
females were taking oral contraceptives.
Microvascular reactivity and systematic error
There were no significant intra-subject differences between
thebaselinemeasurementsoneachofthestudydays(Table1).
The mean baseline values for skin microvascular flow were
4.0¡2.1 PU (day 1) and 4.0¡1.9 PU (day 2) (P=0.74). The
AUC values were not significantly different between days 1
and 2 for the ACh (10937.37¡7010.15 and 9079.15¡5462.00
PU, P=0.22) and SNP (12808.42¡11819.00 and 1083192¡
6481.20 PU, P=0.40) administrations. The AUC absolute
values were also not significantly different between days 1
and 2 for the PORH (706.97¡418.15 and 875.06¡796.36 PU,
P=0.39) and TH (86287.69¡54045.63 and 103987.36¡
60900.94 PU, P=0.26) groups. These results indicate that
there was no systematic error between the two days.
Random errors
An assessment of the repeatability of the responses
between the two different days using the Bland-Altman
analysis is shown in Figure 1. The difference in the
responses between days 1 and 2 is plotted as a function of
the average of the responses of both days for the AUCs of
the vasodilator response induced by ACh, SNP, PORH and
TH.
Table 2 shows the limits of agreement in the day-to-day
measurements of skin microvascular reactivity using LDPM
for each parameter. A preliminary analysis of the data
showed that the variability was not significantly different
between males andfemales(data notshown). Repeatability is
mainly expressed by the ratios of the within-subject standard
deviations to the global means of the variables (WSSD/GM).
The vasodilatory response AUC for PORH showed marked
within-subject variability (WSSD/GM =0.83). By contrast,
the AUC for the skin vasodilatation induced by ACh
exhibited less variability (WSSD/GM =0.52) than the AUC
for PORH and was comparable to the AUCs for SNP and TH
(WSSD/GM of 0.67 and 0.56, respectively).
Intra-class correlation coefficients
The ICC was determined for each variable for all subjects,
and the data are presented in Table 2. All of the variables
studied showed poor ICCs (,0.35). Similar to the other
repeatability indices presented above, the ICC values were
much lower for the AUC for PORH than for the AUC for
ACh. The AUCs for SNP and TH presented intermediate
values.
Sample size calculations
Sample size estimates using the minimum differences that
were expected to be statistically significant for the different
microvascular reactivity measurement techniques in long-
itudinal studies using LDPM are presented in Table 3. The
AUC for PORH required a much larger sample size than did
the other techniques. The AUC for ACh administration
required the smallest sample size, and the AUCs of SNP and
TH required intermediate values.
DISCUSSION
The main finding of the present study is that there is
important within-subject variability that is not related to
systematic error in the evaluation of skin microvascular
reactivity using single-point LDPM. Although it is non-
invasive, operator-independent and easy to perform, LDPM is
hampered by its poor repeatability, particularly in measures
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occlusive hyperemia. Thus, the random error inherent in LDPM
repeatability should be thoroughly evaluated when calculating
the statistical power and sample sizes in longitudinal studies
evaluating endothelial function as a surrogate marker for
cardiovascular disease.
LDPM coupled to skin iontophoresis of endothelial-depen-
dent vasodilators, essentially acetylcholine, has already been
used to demonstrate the existence of endothelial dysfunction
in several cardiometabolic disorders, including arterial hyper-
tension
27,28 ,t y p e1
29–31 and type 2 diabetes,
32 insulin
resistance
33 and the metabolic syndrome itself.
34 However,
all of the studies mentioned above were cross-sectional and
observational, and they included only a small number of
subjects (typically fewer than 50 patients/healthy volunteers).
Table 1 - The mean values for microvascular reactivity
measured one week apart in healthy subjects using laser
Doppler perfusion monitoring.
Parameter Day 1 Day 2 P value
AUC-ACh (PU) 10,937.37 (7,010.15) 9,079.15 (5,462.00) 0.22
AUC-SNP (PU) 12,808.42 (11,819.00) 10,831.92 (6,481.20) 0.40
AUC-TH (PU) 86,287.69 (54,045.63) 103,987.36 (60,900.94) 0.26
AUC-PORH (PU) 706.97 (418.15) 875.06 (796.36) 0.39
The values are presented as the mean (standard deviation).
Ach = acetylcholine, AUC = area under the blood flow/time curve,
SNP = sodium nitroprusside, PORH = post-occlusive reactive hyperemia,
PU = arbitrary perfusion units, and TH = thermal hyperemia.
Figure 1 - Bland-Altman plots for the assessment of the day-to-day repeatability of microvascular reactivity measurements obtained
one week apart in healthy subjects using laser Doppler perfusion monitoring. The difference in the responses measured on the two
days (Day 1– Day 2) is plotted against the average of the responses [K * (Day 1 + Day 2)]. The solid lines correspond to the mean of the
differences, and the dashed lines indicate the 95% limits of agreement for the differences between the days. The values were log-
transformed. Ach = acetylcholine, AUC = area under the blood flow/time curve, SNP = sodium nitroprusside, PORH = post-occlusive
reactive hyperemia, and TH = thermal hyperemia.
Repeatability of skin laser Doppler flowmetry
Tibiric ¸a ´ E et al.
CLINICS 2011;66(4):599-605
602Although most investigators limit their statistical analysis
to the calculation of correlation coefficients, it has been well
established that the simple use of correlation coefficients to
evaluate the repeatability of methods is not adequate.
25 In
fact, this approach evaluates the existence of an association
between values measured on different days but not the
agreement (repeatability) of the measures.
25 An evaluation of
the day-to-day repeatability of LDPM ACh responses using
just the coefficients of variationyielded valuesof up to 42%.
15
When calculating the repeatability of methods, it is
important to differentiate intervention effects from mea-
surement errors. Measurement errors can be divided into
two main components: random and systematic errors.
Random error is always present in a measurement and is
not related to the clinical intervention because it is caused
by inherently unpredictable fluctuations in the readings of
the measuring equipment. By contrast, systematic errors are
predictable biases in measurement, also not related to the
clinical intervention, that can be attributed to the experi-
mental protocol. Therefore, they can be observed in all of the
subjects in question, and they interfere directly with the
accuracy of the measurement. In this situation, the effect of a
clinical intervention must be greater than the systematic
error for it to be detected and considered a real effect
regardless of the sample size. By contrast, random error
directly affects the sample size required to achieve sufficient
power to detect the effects of a clinical intervention.
The results of this study show that there is important
random error in the measurements of microvascular
reactivity performed one week apart in healthy subjects.
Moreover, we did not detect a systematic error in the
measurements. In fact, the values of the AUC of cutaneous
vasodilatation for all of the techniques in question were not
significantly different between days 1 and 2, indicating that
there was no systematic error between days. Moreover, the
minimum differences expected to be statistically significant
according to the sample size for the different techniques
showed that the endothelium-dependent responses induced
by ACh were much more adequate than the responses
induced by PORH because their variability was significantly
lower. This result was confirmed by the analysis of the ratio
between the within-subject standard deviations and the
global means of the values, in which the smallest AUC value
was obtained from the ACh administration. In addition, we
found that sample sizes of about 50 and 25 subjects are
necessary to detect changes of about 30 and 40%, respec-
tively, in the AUC following ACh administration. Our
results also showed that the variability observed in the
responses to SNP and TH was comparable to that observed
in ACh administration. These results imply that the
endothelium-dependent response of the cutaneous micro-
circulation can be better evaluated using pharmacological
rather than physiological provocation. These findings
confirm our previous results showing that the skin micro-
vascular vasodilatory response to iontophoresis with ACh is
significantly reduced in patients with type 1 diabetes
compared to healthy subjects, while the responses to
PORH and skin heating are preserved.
29 In that study, a
significant difference of ,37% between diabetic patients
and healthy controls in the AUC following ACh adminis-
tration was detected using a sample of 50 diabetic patients
and 46 control subjects. The absence of significant differ-
ences in the responses observed using physiological
stimulation in our previous study
29 may be explained by
the higher variability compared to pharmacological (ACh)
stimulation.
In the present study, the analysis of the measurements
obtained on the two days using the method of Bland and
Altman
25 indicated that most of the differences were within
the 95% confidence intervals. The AUC values obtained
using ACh administration exhibited a more uniform
distribution than those obtained from endothelial-depen-
dent vasodilatation induced by physiological stimulation
(PORH and TH).
The intraclass correlation coefficient (ICC), a statistical
measure of between-subject repeatability, was also lower for
the microvascular reactivity resulting from PORH com-
pared to that resulting from ACh. Our results are in close
agreement with those of Roustit et al.,
16 who demonstrated
that the low ICC values obtained from skin LDPM in the
forearm using PORH are related to the high anatomical
variability of capillary density. Even if we had used a
standardized forearm recording site in the present study,
which is rather difficult to maintain in longitudinal studies,
the low repeatability may also have been explained by the
anatomical variation in capillary density at this recording
site. Moreover, in contrast to the vasodilatation curves
Table 2 - An assessment of the limits of agreement in the day-to-day measurements of skin microvascular reactivity
using laser Doppler perfusion monitoring.
Parameter ME (SL/IL) WSSD WSSD/GM Ratio TE ICC
AUC ACh (PU) 1,858.22 (10,015.76/344.76) 5,173.05 0.52 5,111.01 0.338
AUC SNP (PU) 1,976.5 (9,834.75/397.22) 7,863.02 0.67 7,904.24 0.312
AUC TH (PU) 217,699.67 (297,193.05/23,223.26) 53,159.32 0.56 52,776.22 0.160
AUC PORH (PU) 2168.08 (21,024.57/227.57) 659.88 0.83 663.05 0.087
Ach = acetylcholine, AUC = area under the blood flow/time curve, ICC = intraclass correlation coefficient, ME = mean error (SL = superior limit and IL =
inferior limit), SNP = sodium nitroprusside, PORH = post-occlusive reactive hyperemia, PU = arbitrary perfusion units, TH = thermal hyperemia, Ratio
WSSD/GM = ratio between within-subject standard deviation and global mean values, TE = typical error, and WSSD = within-subject standard deviation.
Table 3 - Estimates of the minimum differences expected
to be statistically significant according to the sample size
under different conditions of microvascular reactivity in
longitudinal studies using laser Doppler perfusion
monitoring.
Sample size
Parameter 50 25 20 10
AUC-ACh (PU) 2,927 4,139 4,627 6,544
AUC-SNP (PU) 4,448 6,291 7,033 9,947
AUC-TH (PU) 30,072 42,528 47,548 67,242
AUC-PORH (PU) 374 528 591 835
Ach = acetylcholine, AUC = area under the blood flow/time curve,
SNP = sodium nitroprusside, PORH = post-occlusive reactive hyperemia,
PU = arbitrary perfusion units, and TH = thermal hyperemia.
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time spans, the PORH curves were recorded until the
microvascular flow returned to the baseline values, thus
generating recordings of different durations. This character-
istic could have contributed to the poor repeatability of the
microvascular flow responses to PORH. Finally, ICC is by
definition population-based and thus cannot be used for
study design and sample size calculations.
Some limitations of our study population should be
discussed. About 50% of the study volunteers were healthy
young women who were taking oral contraceptives.
Measurement of the day-to-day variability of LDPM using
measurements obtained one week apart implies different
hormonal states at days 1 and 2. Considering that the aim of
the study was to investigate the variability of methodologies for
evaluating microvascular function under real-life conditions, it
was important to include volunteers of both sexes. Other
studies testing the variability of laser-Doppler techniques used
similar study populations. Roustit et al.
16 and Cracowski et al.,
35
for example, also investigated single-point LDPM using a
population that included 50% females, all of whom were taking
oral contraceptives. Other studies that have included up to 50%
females do not report on their use of contraceptives or the
phases of their menstrual cycles.
18,36–41 Finally, the day-to-day
variability was not different between the males and females in
our study.
In conclusion, our results confirm and extend those of
Roustit et al.
16 by showing that single-point laser Doppler
monitoring has low reproducibility in the human forearm.
Newer full-field imaging methods, such as laser Doppler
imaging and laser speckle contrast imaging, appear to have
a much better inter-day reproducibility
42 than LDPM, and
thus their use should be encouraged. Nevertheless, a recent
study comparing LDPM skin blood-flow responses elicited
by acetylcholine to flow-mediated dilation in the brachial
artery
43 showed a high correlation between the endothelial
responses in the large arteries and skin microcirculation.
Finally, considering the important random error in the day-
to-day variability of evaluating microvascular endothelial
function using single-point LDPM, we propose the use of an
original and robust statistical methodology for designing
prospective clinical studies.
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